Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v4-EN
Language French English
Date Updated 2025-10-15 2025-10-15
Drug Identification Number 02139480 02139480
Brand name FOLIC ACID INJECTION, USP FOLIC ACID INJECTION, USP
Common or Proper name FOLIC ACID INJECTION, USP FOLIC ACID INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients FOLIC ACID FOLIC ACID
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 mL 10 mL
ATC code B03BB B03BB
ATC description VITAMIN B12 AND FOLIC ACID VITAMIN B12 AND FOLIC ACID
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2025-11-01 2025-11-01
Actual start date 2025-10-14 2025-10-14
Estimated end date 2026-01-15 2026-01-15
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to a further increase in demand, we have encountered a supply interruption on our Folic Acid Injection, USP 5 mg/mL, 10 mL Vial earlier than expected. Inventory has now been depleted effective October 14, 2025. We estimate availability of stock by January 15, 2026. Fresenius Kabi Canada regrets to advise that due to a further increase in demand, we have encountered a supply interruption on our Folic Acid Injection, USP 5 mg/mL, 10 mL Vial earlier than expected. Inventory has now been depleted effective October 14, 2025. We estimate availability of stock by January 15, 2026.
Health Canada comments